President Donald Trump said Sunday that U.S. regulators have given an emergency use authorization for a coronavirus treatment involving blood plasma donated by people who have recovered from the disease. Today, we issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of hospitalized COVID-19 patients as part of the agency’s ongoing efforts to fight #COVID19. Though blood plasma donated from recovered COVID-19 patients is considered safe, top scientists said the clinical trials have not yet proved whether it is effective enough for treating the disease caused by the virus. @scottgottliebMD tells @margbrennan that it is likely related to an emergency use authorization to allow more commercial distribution for plasma for #COVID19 patients. pic.twitter.com/8xL5K6hDhz — Face The Nation (@FaceTheNation) August 23, 2020Trump said the federal government provided $48 million to fund a Mayo Clinic study that tested the efficacy of convalescent plasma for COVID-19 patients.

Source: Huffington Post August 23, 2020 22:30 UTC